Data as of Q4 2025 (Dec 31, 2025)

PSP Research LLC

•CIK: 2106939•Filing: Q4 2025

PSP Research LLC manages $114M across a diversified portfolio of 85 positions. The fund exhibits a significant allocation to short-term treasuries, with SGOV representing the largest holding at $70.3M. Remaining capital is spread across smaller, concentrated positions, including notable allocations to PRAX, TVTX, and TYRA, each at $0.6M. This structure suggests a defensive posture with substantial liquidity management alongside targeted, smaller-cap equity exposure.

Total AUM
$114.4M
QoQ Performance
N/A
Positions
85
Top 10 Concentration
65.8%
Latest Filing
Q4 2025

Top Holdings Allocation

SGOV
SGOV61.4%
PRAX0.5%
TVTX0.5%
TYRA0.5%
PHARVARIS0.5%
JAZZ0.5%
TCE20.5%
CGON0.5%

📈 Biggest Buys

SGOV
ISHARES TR
NEW
61.4% of portfolio
PRAX
PRAXIS PRECISION MEDICINES I
NEW
0.5% of portfolio
TVTX
TRAVERE THERAPEUTICS INC
NEW
0.5% of portfolio
TYRA
TYRA BIOSCIENCES INC
NEW
0.5% of portfolio
—
PHARVARIS N V
NEW
0.5% of portfolio

📉 Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%

📌 Top Holdings

SGOV61.4%
ISHARES TR
$70.3M
PRAX0.5%
PRAXIS PRECISION MEDICINES I
$584.2K
TVTX0.5%
TRAVERE THERAPEUTICS INC
$583.5K
TYRA0.5%
TYRA BIOSCIENCES INC
$574.5K
JAZZ0.5%
JAZZ PHARMACEUTICALS PLC
$553.9K

⚖️ Compare Fund

Compare this fund's holdings with other hedge funds.

🎯 Fund Movement Signals

See AI-analyzed fund movement signals and accumulation patterns.

👤 Insider Trading

See what corporate insiders are buying and selling.